BIOSTAR PHARMACEUTICALS, INC.
BSPM evidence brief
What we can confirm
- BioSniper Score:
- 6.7 / 10
- Market Cap:
- $263
- Lead Asset:
- xin ao xing oleanolic acid (Approved)
What it means
What to watch
Prepared research question
What matters most for BSPM—catalysts, financial risk and supporting evidence?
Traceable citations · Unknowns marked
BioSniper Score
Based on 2 of 6 signals
Limited data coverage
Market Cap
$263
Cash Runway
—
Lead Asset
xin ao xing oleanolic acid (Approved)
Next Catalyst
—
Tracking 1 pipeline candidate · 4 clinical trials for BIOSTAR PHARMACEUTICALS, INC..
Run BIOSTAR PHARMACEUTICALS, INC. through your own thesis
Use the pipeline, catalyst, financial, FDA, and market facts on this page as inputs to a protocol you control.
Your protocol can:
- Turn available BIOSTAR PHARMACEUTICALS, INC. facts into screen rules or deeper checks
- Show cited findings, blockers, and unresolved evidence together
- Save the logic and rerun it as the company evidence changes
Score breakdownBased on 2 of 6 signals · derived from public data
Cash runway data unavailable
Financial health data unavailable
Lead: Approved
1 candidate
No upcoming catalysts tracked
No insider transactions in the last 180 days
Pipeline
Regulatory
Financials
Short Interest
as of May 13, 2026- % of float
- 7.7%
- Days to cover
- 3.0
- Shares short
- 170,439
- Daily short volume
- -
Short percent of float and days-to-cover reflect reported short positioning. Daily short volume is the exchange-reported short share of a single day's trading volume and is noisier. See the most-shorted biotech ranking →
BSPM short interestGovernance
Frequently asked questions
What is BIOSTAR PHARMACEUTICALS, INC.'s lead drug candidate?
BIOSTAR PHARMACEUTICALS, INC.'s most advanced tracked candidate is xin ao xing oleanolic acid (Approved) for Chronic hepatitis B.
Who is the CEO of BIOSTAR PHARMACEUTICALS, INC.?
Mr. Ronghua Wang Ph.D. is the chief executive officer of BIOSTAR PHARMACEUTICALS, INC. (BSPM).
Where is BIOSTAR PHARMACEUTICALS, INC. headquartered?
BIOSTAR PHARMACEUTICALS, INC. (BSPM) is headquartered in Xianyang, China.
What therapeutic areas does BIOSTAR PHARMACEUTICALS, INC. focus on?
BIOSTAR PHARMACEUTICALS, INC. develops therapies across Oncology, Infectious Disease.
The AI overview and BioSniper Score are neutral, data-derived signals built from public SEC filings, ClinicalTrials.gov and FDA records — not investment advice.